JA
ABMD

JOYN Advisors’s Abiomed Inc ABMD Stock Holding History

JOYN Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-380
Closed -$124K – 1557
2018
Q4 		$124K Buy
380
+18
+5% +$6.25K 0.03% 166
2018
Q3 		$163K Sell
362
-18
-5% -$7.1K 0.03% 159
2018
Q2 		$155K Buy
380
+118
+45% +$42.7K 0.03% 164
2018
Q1 		$76K Buy
+262
New +$66.4K 0.02% 354

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JOYN Advisors's ABMD Position: Q1 2019 in Review

JOYN Advisors sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 380 shares — an estimated $124K sold.

JOYN Advisors first reported a position in ABMD in Q1 2018 and held it in 4 quarters. The position peaked at $163K in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • JOYN Advisors reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 380 Abiomed Inc shares in Q1 2019, an estimated $124K.
  • JOYN Advisors first reported a position in Abiomed Inc in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Abiomed Inc position peaked at $163K in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.